Inpharma Weekly

, Volume 1179, Issue 1, pp 13–14 | Cite as

Keeping up with the lytics

  • Rosalind Black
Newsletter Article

Abstract

At present, alteplase [rt-PA] is the only thrombolytic drug approved for use in acute ischaemic stroke and it must be administered within 3 hours of stroke onset. Data reported at the 24th International Conference on Stroke and Cerebral Circulation [ Nashville, US; February 1999 ] included contradictory reports on the effectiveness of alteplase administered up to 6 hours after stroke onset, the use of alteplase in clinical practice and the promising efficacy of other thrombolytic drugs.

Keywords

Acute Stroke Acute Ischaemic Stroke Alteplase Stroke Onset Protocol Violation 

Copyright information

© Adis International Ltd 1999

Authors and Affiliations

  • Rosalind Black

There are no affiliations available

Personalised recommendations